by Reginald Swift | Dec 17, 2018 | News and Updates
Lawrence Award Program Honors the Achievement LAWRENCE, MA December 17, 2018 — Rubix LS has been selected for 2018 Best of Lawrence Award in the Research and Product Development category by the Lawrence Award Program. Each year, the Lawrence Award Program...
by Reginald Swift | Dec 10, 2018 | News and Updates
Lawrence, MA – Today, Rubix LS announced the success of a critical milestone within the Phase IIa study of Project Hercules. Designed as an implantable combination device with wider applications toward targeting osteopenia, arthrodesis and certain malignancies...
by Reginald Swift | Nov 26, 2018 | Articles
Anthrax. Ebola. Smallpox. These are just a few of the biological agents that could be weaponized for a bioterrorism attack and unlike a bombing or shooting, these microbial agents can incubate for days or weeks going unnoticed until unrelenting illnesses or deaths...
by Reginald Swift | Nov 15, 2018 | Articles
Creating a new drug is undoubtedly harrowing. The success rate of clinical trials is dependent on many factors such as patient enrollment, efficacy, bureaucracy, and awareness of the general public. These concerns are influential factors that ultimately affect which...
by Reginald Swift | Nov 5, 2018 | Articles
On the quest to push the boundaries of innovation to develop and launch new products, companies have to address an increasing number of regulatory requirements which span multiple geographies, business activities and functions. While the life sciences industry has...
